MHHi008-A

Registration Summary:

A P E C

CD34+hPBHSC_GMPDU_SeV-iPS8

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	MHHi008-A
Cite as:	MHHi008-A (RRID:CVCL_VS38)
Alternative name(s)	CD34+hPBHSC_GMPDU_SeV-iPS8
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	7th September 2018
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Hannover Medical School (MHH)
External Databases
Cellosaurus	CVCL_VS38
Wikidata	Q95989471
General Information
Publications	Haase A et al. GMP-compatible manufacturing of three iPS cell lines from human peripheral blood. Stem cell research. 2019 Mar;35:101394. Manstein F et al. High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling. Stem cells translational medicine. 2021 Jul;10(7):1063-1080. Pflaum M et al. Towards Biohybrid Lung: Induced Pluripotent Stem Cell Derived Endothelial Cells as Clinically Relevant Cell Source for Biologization. Micromachines. 2021 Aug 19;12(8). Manstein F et al. Process control and in silico modeling strategies for enabling high density culture of human pluripotent stem cells in stirred tank bioreactors. STAR protocols. 2021 Dec 17;2(4):100988. Cuesta-Gomez N et al. Suspension culture improves iPSC expansion and pluripotency phenotype. Stem cell research & therapy. 2023 Jun 6;14(1):154. Ullmann K et al. Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation. Stem cell research & therapy. 2024 Mar 25;15(1):89. Kriedemann N et al. Protein-free media for cardiac differentiation of hPSCs in 2000 mL suspension culture. Stem cell research & therapy. 2024 Jul 18;15(1):213.

hIPSC Derivation

General